English

REGADO BIOSCIENCES INC

EDGAR

RGDO Quarterly report amendment (10-Q/A) · filed 2016-09-09

20 filing records in this dataset, filed from 2013-04-29 to 2016-09-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2015 Q1 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-5.97 million USD

2015 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -5974000 USD Source

Free cash flow

-6 million USD

2015 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -5974000 USD Source
Capital Expenditure: 22000 USD Source

Cash and cash equivalents: 40.7 million USD 2016-06-30 Source
Exact value

40692000 USD
Long-term debt including current maturities: 14.9 million USD 2015-06-30 Source
Exact value

14943000 USD
Shares outstanding: 18.8 million shares 2016-06-30 Source
Exact value

18815689 shares

Reported share-count change

6.69% · 1.18 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

17635149 shares · 2015-06-30· Source
18815689 shares · 2016-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-57.2 million USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Net income: -22211000 USD · 2015-07-01 – 2015-09-30 Source
Net income: -9387000 USD · 2015-10-01 – 2015-12-31 Source
Net income: -12221000 USD · 2016-01-01 – 2016-03-31 Source
Net income: -13343000 USD · 2016-04-01 – 2016-06-30 Source

Operating cash flow

-37.3 million USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Operating cash flow: -25197000 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -15756000 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -31294000 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -25197000 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -10086000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -21728000 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -10086000 USD · 2016-01-01 – 2016-03-31 Source

Capital expenditure

39 thousand USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Capital expenditure: 22000 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 31000 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 22000 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 31000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 31000 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 39000 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 31000 USD · 2015-01-01 – 2015-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-09-09.

Financial data available through: 2015-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 4 of 11 periods available· newest 2015-12-31
Net income: 4 of 11 periods available· newest 2015-12-31
Operating cash flow: 4 of 11 periods available· newest 2015-12-31
Capital expenditure: 4 of 11 periods available· newest 2015-12-31
Total assets: 4 of 11 periods available· newest 2015-12-31
Total liabilities: 4 of 11 periods available· newest 2015-12-31
Current assets: 4 of 11 periods available· newest 2015-12-31
Current liabilities: 4 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2015-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2014-12-31
Shares outstanding: 4 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 25.52 million

Prior period

−USD 24.1 million

2014-01-01 – 2014-12-31
Current period

−USD 49.62 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-49617000 − -24100000 = -25517000 USD

-24100000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-49617000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · REGADO BIOSCIENCES INC · 2015-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Year-over-year change in Net income: -25517000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -49617000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#119132 Filing: 000156459016013992 Input fundies:NetIncome: -24100000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#119286 Filing: 000156459016013992
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 12.63 million

Prior period

−USD 18.67 million

2014-01-01 – 2014-12-31
Current period

−USD 31.29 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-31294000 − -18665000 = -12629000 USD

-18665000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-31294000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · REGADO BIOSCIENCES INC · 2015-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Year-over-year change in Operating cash flow: -12629000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -31294000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#149819 Filing: 000156459016013992 Input fundies:OperatingCashFlow: -18665000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150071 Filing: 000156459016013992
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-78.3%

Prior period

USD 180,000

2014-01-01 – 2014-12-31
Current period

USD 39,000

2015-01-01 – 2015-12-31

Exact inputs and evidence

39000 − 180000 = -141000 USD

180000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
39000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · REGADO BIOSCIENCES INC · 2015-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Year-over-year change in Capital expenditure: -141000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 39000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150756 Filing: 000156459016013992 Input fundies:CapitalExpenditure: 180000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150964 Filing: 000156459016013992
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2012 2012-01-01 – 2012-12-31	−USD 13.06 million Exact value Exact value: -13062000 USD 2012-01-01 – 2012-12-31: -13062000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGADO BIOSCIENCES INC · 2012-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Net Income: -13062000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13062000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000119312514095713/rgdo-20131231.xml#624221 Filing: 000119312514095713 The citation records this snapshot. The page link may show a newer release later.	−USD 14.23 million Exact value Exact value: -14229000 USD 2012-01-01 – 2012-12-31: -14229000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGADO BIOSCIENCES INC · 2012-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Operating Cash Flow: -14229000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14229000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000119312514095713/rgdo-20131231.xml#618558 Filing: 000119312514095713 The citation records this snapshot. The page link may show a newer release later.	USD 17,000 Exact value Exact value: 17000 USD 2012-01-01 – 2012-12-31: 17000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGADO BIOSCIENCES INC · 2012-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Capital Expenditure: 17000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000119312514095713/rgdo-20131231.xml#624962 Filing: 000119312514095713 The citation records this snapshot. The page link may show a newer release later.	−USD 14.25 million Calculation and evidence -14229000 − 17000 USD Exact free cash flow: -14246000 USD 2012-01-01 – 2012-12-31: -14229000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 17000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGADO BIOSCIENCES INC · 2012-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Free cash flow: -14246000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14229000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000119312514095713/rgdo-20131231.xml#618558 Filing: 000119312514095713 Input fundies:CapitalExpenditure: 17000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000119312514095713/rgdo-20131231.xml#624962 Filing: 000119312514095713 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 18.59 million Exact value Exact value: -18589000 USD 2013-01-01 – 2013-12-31: -18589000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGADO BIOSCIENCES INC · 2013-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Net Income: -18589000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18589000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#119440 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.	−USD 16.89 million Exact value Exact value: -16894000 USD 2013-01-01 – 2013-12-31: -16894000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGADO BIOSCIENCES INC · 2013-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Operating Cash Flow: -16894000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16894000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150323 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.	USD 1,000 Exact value Exact value: 1000 USD 2013-01-01 – 2013-12-31: 1000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGADO BIOSCIENCES INC · 2013-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Capital Expenditure: 1000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#151173 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.	−USD 16.9 million Calculation and evidence -16894000 − 1000 USD Exact free cash flow: -16895000 USD 2013-01-01 – 2013-12-31: -16894000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 1000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGADO BIOSCIENCES INC · 2013-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Free cash flow: -16895000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16894000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150323 Filing: 000156459016013992 Input fundies:CapitalExpenditure: 1000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#151173 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 24.1 million Exact value Exact value: -24100000 USD 2014-01-01 – 2014-12-31: -24100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGADO BIOSCIENCES INC · 2014-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Net Income: -24100000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24100000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#119286 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.	−USD 18.67 million Exact value Exact value: -18665000 USD 2014-01-01 – 2014-12-31: -18665000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGADO BIOSCIENCES INC · 2014-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Operating Cash Flow: -18665000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18665000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150071 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.	USD 180,000 Exact value Exact value: 180000 USD 2014-01-01 – 2014-12-31: 180000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGADO BIOSCIENCES INC · 2014-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Capital Expenditure: 180000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 180000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150964 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.	−USD 18.85 million Calculation and evidence -18665000 − 180000 USD Exact free cash flow: -18845000 USD 2014-01-01 – 2014-12-31: -18665000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 180000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGADO BIOSCIENCES INC · 2014-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Free cash flow: -18845000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18665000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150071 Filing: 000156459016013992 Input fundies:CapitalExpenditure: 180000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150964 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 49.62 million Exact value Exact value: -49617000 USD 2015-01-01 – 2015-12-31: -49617000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGADO BIOSCIENCES INC · 2015-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Net Income: -49617000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -49617000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#119132 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.	−USD 31.29 million Exact value Exact value: -31294000 USD 2015-01-01 – 2015-12-31: -31294000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGADO BIOSCIENCES INC · 2015-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Operating Cash Flow: -31294000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31294000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#149819 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.	USD 39,000 Exact value Exact value: 39000 USD 2015-01-01 – 2015-12-31: 39000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGADO BIOSCIENCES INC · 2015-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Capital Expenditure: 39000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 39000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150756 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.	−USD 31.33 million Calculation and evidence -31294000 − 39000 USD Exact free cash flow: -31333000 USD 2015-01-01 – 2015-12-31: -31294000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 39000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGADO BIOSCIENCES INC · 2015-12-31 REGADO BIOSCIENCES INC (edgar:1311596) Free cash flow: -31333000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311596?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31294000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#149819 Filing: 000156459016013992 Input fundies:CapitalExpenditure: 39000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311596/000156459016013992/tbra-20151231.xml#150756 Filing: 000156459016013992 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 851 latest values · 851 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001311596, 1311596, RGDO, TBRA, edgar:1311596

Also known as REGADO BIOSCIENCES INC, Regado Biosciences Inc, Tibira Therapeutics, Inc., Tobira Therapeutics, Inc.

REGADO BIOSCIENCES INC

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation